# Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases

> **NCT00858429** · PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 18 (actual)

## Conditions studied

- Liver Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** capecitabine
- **RADIATION:** yttrium Y 90 glass microspheres

## Key facts

- **NCT ID:** NCT00858429
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-01
- **Primary completion:** 2014-03-19
- **Final completion:** 2014-07-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858429, "Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00858429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*